Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Systematic review of outcomes and endpoints in acute migraine clinical trials.

PMID: 33611818 ·

C, a, r, r, i, e, , R, , H, o, u, t, s, ;, , J, a, m, e, s, , S, , M, c, G, i, n, l, e, y, ;, , T, r, a, c, y, , K, , N, i, s, h, i, d, a, ;, , D, a, w, n, , C, , B, u, s, e, ;, , R, , J, , W, i, r, t, h, ;, , D, a, v, i, d, , W, , D, o, d, i, c, k, ;, , P, e, t, e, r, , J, , G, o, a, d, s, b, y, ;, , R, i, c, h, a, r, d, , B, , L, i, p, t, o, n

JournalHeadache
Year
PMID33611818

Abstract

To review the acute migraine clinical trial literature and provide a summary of the endpoints and outcomes used in such trials. A systematic literature review, following a prespecified (but unregistered) protocol developed to adhere to recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, was conducted to understand endpoints and outcomes used in acute migraine clinical trials. Predefined terms were searched in PubMed to locate clinical trials assessing acute

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑